Banque Pictet & Cie Sa Moderna, Inc. Transaction History
Banque Pictet & Cie Sa
- $14.9 Billion
- Q4 2024
A detailed history of Banque Pictet & Cie Sa transactions in Moderna, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 3,132,974 shares of MRNA stock, worth $112 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
3,132,974
Previous 3,155,399
0.71%
Holding current value
$112 Million
Previous $211 Million
38.22%
% of portfolio
0.87%
Previous 1.61%
Shares
23 transactions
Others Institutions Holding MRNA
# of Institutions
925Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.44 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.38 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$910 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$626 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$260 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...